Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Micronutrients and Metformin in PCOS
NCT05653895Completed
- Sponsor
- Khyber Medical University
- Start
- Dec 2022
- Primary completion
- Dec 2023
- Modality
- Peptides, Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of resveratrol, acetyl-l-carnitine, arginine and coenzyme q10 in polycystic ovary syndrome (PCOS) (4 arms), sponsored by Khyber Medical University. Primary endpoints: Insulin Resistance at 6 months, Menstrual Irregularities at 6 months and 2 more. Started Dec 2022; status: completed.
02
Drugs
resveratrolacetyl-l-carnitineargininecoenzyme q10
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on NCT05653895.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05653895.